patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: What does everyone think about this news...

What does everyone think about this news...

posted on May 15, 2008 09:03AM

Pluristem Therapeutics Inc. (PSTI) announced that it will remove the restrictive legends on 3.9 million shares of common stock of a total of 4.4 million shares and warrant shares sold in its PIPE private placement in May 2007. Under the applicable agreements, purchasers agreed not to sell shares and warrant shares purchased in the placement for proceeds in excess of 125% of their purchase price in the second year following the closing, and an increasing percentage in the third and fourth year. The Company is removing the restrictive legends on a portion of the shares in order to facilitate the ability of the PIPE shareholders to sell shares no longer subject to the lock-up.

This might show confidence that the company is willing to do this, but - BWDIK

Share
New Message
Please login to post a reply